Panitumumab Metastatic colorectal Not 25/01/2012 No Ca (2nd line) approved Dasatinib CML dasatinib, not approved 13/01/2012 No nilotinib, imatinib (intolerant, resistant) Imatinib CML dasatinib, Not 13/01/2012 No nilotinib, imatinib approved (intolerant, resistant) Fulvestrant Breast Ca Not 14/12/2011 No approved Panitumumab Metastatic colorectal Terminated 14/12/2011 No Ca (2nd line) Bendamustine Indolent NHL Not 27/10/2011 No approved Agomelatine Depression Not 27/07/2011 No approved Erlotinib NSCLC - maintenance Not 29/06/2011 No approved Golimumab RA Terminated 22/06/2011 No Cilostazol Intermiittent Not 25/05/2011 No claudication approved associated with peripheral vasular disease Inositol Intermiittent Not 25/05/2011 No nicotinate claudication Approved associated with peripheral vasular disease Pentoxifylline Intermiittent Not 25/05/2011 No claudication approved associated with peripheral vasular disease Trabectedin Relapsed ovarian Ca Not 27/04/2011 No approved Everolimus Advanced RCC (2nd Not 19/04/2011 No line) approved Bevacizumab Metastatic breast Ca Not 23/02/2011 No approved Raloxifene Primary prevention Not 26/01/2011 No of osteoporosis approved
Panitumumab Metastatic colorectal Ca (2nd line) Not approved 25/01/2012 No Dasatinib CML dasatinib, nilotinib, imatinib (intolerant, resistant) not approved 13/01/2012 No Imatinib CML dasatinib, nilotinib, imatinib (intolerant, resistant) Not approved 13/01/2012 No Fulvestrant Breast Ca Not approved 14/12/2011 No Panitumumab Metastatic colorectal Ca (2nd line) Terminated 14/12/2011 No Bendamustine Indolent NHL Not approved 27/10/2011 No Agomelatine Depression Not approved 27/07/2011 No Erlotinib NSCLC - maintenance Not approved 29/06/2011 No Golimumab RA Terminated 22/06/2011 No Cilostazol Intermiittent claudication associated with peripheral vasular disease Not approved 25/05/2011 No Inositol nicotinate Intermiittent claudication associated with peripheral vasular disease Not Approved 25/05/2011 No Pentoxifylline Intermiittent claudication associated with peripheral vasular disease Not approved 25/05/2011 No Trabectedin Relapsed ovarian Ca Not approved 27/04/2011 No Everolimus Advanced RCC (2nd line) Not approved 19/04/2011 No Bevacizumab Metastatic breast Ca Not approved 23/02/2011 No Raloxifene Primary prevention of osteoporosis Not approved 26/01/2011 No
NICE-TA-Adherence-Check-list-September-2013-HAST.docx